BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28689250)

  • 1. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients.
    Oh SY; Shin SW; Koh SJ; Bae SB; Chang H; Kim JH; Kim HJ; Hong YS; Park KU; Park J; Lee KH; Lee NR; Lee JL; Jang JS; Hong DS; Lee SS; Baek SK; Choi DR; Chung J; Oh SC; Han HS; Yun HJ; Sym SJ; Yoon SY; Choi IS; Shim BY; Kang SY; Kim SR; Kim HJ
    Support Care Cancer; 2017 Dec; 25(12):3759-3767. PubMed ID: 28689250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer pain.
    Baek SK; Shin SW; Koh SJ; Kim JH; Kim HJ; Shim BY; Kang SY; Bae SB; Yun HJ; Sym SJ; Han HS; Gil HY
    PLoS One; 2021; 16(8):e0252781. PubMed ID: 34403429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities.
    Oosterling A; te Boveldt N; Verhagen C; van der Graaf WT; Van Ham M; Van der Drift M; Vissers K; Engels Y
    Pain Pract; 2016 Apr; 16(4):413-21. PubMed ID: 25857631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea: Results from the NLBP Outcomes Research.
    Hong JT; Kim JH; Kim KS; Lee CS; Shin HC; Kim WK; Kim JH; Lee JK; Kim IS; Ha Y; Im SB; Kim SW; Han IH; Shin JJ; Rim B; Suk KS; Kim JH; Park YS; Chang BS; Jun DS; Kim YH; Lee JH; Min WK; Lee JS; Park SY; Oh IS; Hong JY; Seo BJ; Kim YJ; Lee J
    Medicine (Baltimore); 2018 Aug; 97(35):e11919. PubMed ID: 30170385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials.
    Mendoza TR; Dueck AC; Shi Q; Ma H; Zhang J; Qian Y; Cleeland CS
    Eur J Pain; 2018 Mar; 22(3):565-571. PubMed ID: 29082574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic cancer pain: prevalence, pathophysiology, and management.
    Yoon SY; Oh J
    Korean J Intern Med; 2018 Nov; 33(6):1058-1069. PubMed ID: 29929349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of neuropathic pain in radiotherapy oncology units.
    Mañas A; Monroy JL; Ramos AA; Cano C; López-Gómez V; Masramón X; Pérez M;
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):511-20. PubMed ID: 20832183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain Treatment and Cancer Patients: Are we Heeding Quality of Life?
    Mio Pos A; Wainstein AJA; Aleixo M; Vieira BAS; Drummond-Lage AP
    J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):63-71. PubMed ID: 36630265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
    Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
    Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
    Tombal B; Saad F; Penson D; Hussain M; Sternberg CN; Morlock R; Ramaswamy K; Ivanescu C; Attard G
    Lancet Oncol; 2019 Apr; 20(4):556-569. PubMed ID: 30770294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital-based Investigation of Prevalence, Etiology, Assessment, and Treatment.
    Lu F; Song L; Xie T; Tian J; Fan Y; Liu H
    Pain Pract; 2017 Jan; 17(1):88-98. PubMed ID: 26991802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center.
    Massaccesi M; Deodato F; Caravatta L; Macchia G; Padula GD; Di Rito S; Woldemariam AA; Rossi M; Di Falco C; Tambaro R; Mignogna S; Flocco M; Pacelli F; Valentini V; Cellini N; Morganti AG
    Clin J Pain; 2013 Nov; 29(11):944-7. PubMed ID: 23370088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
    Perrot S; Lantéri-Minet M
    Eur J Pain; 2019 Jul; 23(6):1117-1128. PubMed ID: 30793414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of neuropathic pain: results from a cross-sectional survey.
    McDermott AM; Toelle TR; Rowbotham DJ; Schaefer CP; Dukes EM
    Eur J Pain; 2006 Feb; 10(2):127-35. PubMed ID: 16310716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Pain Features Relate to Quality of Life More than Physiopathology: A Cross-Sectional Evaluation in Pain Clinics.
    Pérez C; Margarit C; Sánchez-Magro I; de Antonio A; Villoria J
    Pain Pract; 2017 Sep; 17(7):866-878. PubMed ID: 27782366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic pain after groin hernia repair: pain characteristics and impact on quality of life.
    Bande D; Moltó L; Pereira JA; Montes A
    BMC Surg; 2020 Jul; 20(1):147. PubMed ID: 32631293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of pain and its association with quality of life of patients with heart failure in a developing country: findings from a multicenter cross-sectional study.
    Mhesin D; Nazzal H; Amerah J; Azamtta M; Ismail Y; Daralammouri Y; Abdalla MA; Jaber MM; Koni AA; Zyoud SH
    BMC Cardiovasc Disord; 2022 Sep; 22(1):426. PubMed ID: 36171539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Cohabitants Reliably Complete Questionnaires for Patients in a Terminal Cancer Stage when Assessing Quality of Life, Pain, Depression, and Anxiety?
    Groot OQ; Paulino Pereira NR; Bongers MER; Ogink PT; Newman ET; Verlaan JJ; Raskin KA; Lozano-Calderon SA; Schwab JH
    Clin Orthop Relat Res; 2021 Apr; 479(4):792-801. PubMed ID: 33165035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.
    Kerckhove N; Mallet C; Pereira B; Chenaf C; Duale C; Dubray C; Eschalier A
    BMJ Open; 2016 Dec; 6(12):e013530. PubMed ID: 27986742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sublingual fentanyl tablets for the management of breakthrough pain in patients with chronic musculoskeletal pain with neuropathic component: multicenter prospective study.
    Cánovas-Martínez L; Carceller-Ruiz JJ; Díaz-Parada P; Illodo-Miramontes G; Freire-Vila E; De la Iglesia-López A; Iglesias BG; López-Ulloa B; Domínguez-Suárez E; Camba-Rodríguez A
    Clin Drug Investig; 2015 Mar; 35(3):169-77. PubMed ID: 25655006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.